[The course of erythema following epicutaneous application of nonyl acid vanillyl-amide and nicotinic acid-beta-butoxyethyl ester].
D000577:Amides / Q000494:pharmacology*; D004890:Erythema; D005227:Fatty Acids; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D014466:Ultraviolet Rays / Q000009:adverse effects*; D014641:Vanillic Acid / Q000031:analogs & derivatives
D000577:Amides; D005227:Fatty Acids; D009539:Nicotinic Acids; D009525:Niacin; C008776:pelargonic acid; D014641:Vanillic Acid
AMIDES/effects; ERYTHEMA/experimental; NICOTINIC ACID/derivatives; ULTRAVIOLET RAYS/injurious effects; VANILLIC ACID/derivatives
Verlauf des Erythems nach epicutaner Anwendung von Nonylsäurevanillylamid und Nikotinsäure-beta-Butoxyaethylester.